Literature DB >> 33423384

Diagnosis of Mycobacterium bovis infection in free-ranging common hippopotamus (Hippopotamus amphibius).

Tanya J Kerr1, Wynand J Goosen1, Rachiel Gumbo1, Lin-Mari de Klerk-Lorist2, Oonagh Pretorius3, Peter E Buss4, Léanie Kleynhans1, Konstantin P Lyashchenko5, Robin M Warren1, Paul D van Helden1, Michele A Miller1.   

Abstract

Bovine tuberculosis (bTB), caused by Mycobacterium bovis (M. bovis) infection, is a multi-host disease which negatively affects the wildlife industry, with adverse consequences for conservation, ecotourism, and game/wildlife sales. Although interspecies transmission has been reported between some wildlife hosts, the risk of spread in complex ecosystems is largely unknown. As a controlled disease, tools for accurate detection of M. bovis infection are crucial for effective surveillance and management, especially in wildlife populations. There are, however, limited species-specific diagnostic tests available for wildlife. Hippopotamuses are rarely tested for M. bovis infection, and infection has not previously been confirmed in these species. In this study, blood and tissue samples collected from common hippopotamus (Hippopotamus amphibius) residing in a bTB-endemic area, the Greater Kruger Protected area (GKPA), were retrospectively screened to determine whether there was evidence for interspecies transmission of M. bovis, and identify tools for M. bovis detection in this species. Using the multi-species DPP® VetTB serological assay, a bTB seroprevalence of 8% was found in hippopotamus from GKPA. In addition, the first confirmed case of M. bovis infection in a free-ranging common hippopotamus is reported, based on the isolation in mycobacterial culture, genetic speciation and detection of DNA in tissue samples. Importantly, the M. bovis spoligotype (SB0121) isolated from this common hippopotamus is shared with other M. bovis-infected hosts in GKPA, suggesting interspecies transmission. These results support the hypothesis that M. bovis infection may be under recognized in hippopotamus. Further investigation is needed to determine the risk of interspecies transmission of M. bovis to common hippopotamus in bTB-endemic ecosystems and evaluate serological and other diagnostic tools in this species.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  zzm321990Mycobacterium boviszzm321990; DPP® Vet TB Assay; GeneXpert® MTB/RIF Ultra qPCR Assay; Greater Kruger Protected Area; common hippopotamus; interspecies transmission

Mesh:

Year:  2021        PMID: 33423384     DOI: 10.1111/tbed.13989

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  3 in total

Review 1.  Review of Diagnostic Tests for Detection of Mycobacterium bovis Infection in South African Wildlife.

Authors:  Netanya Bernitz; Tanya J Kerr; Wynand J Goosen; Josephine Chileshe; Roxanne L Higgitt; Eduard O Roos; Christina Meiring; Rachiel Gumbo; Candice de Waal; Charlene Clarke; Katrin Smith; Samantha Goldswain; Taschnica T Sylvester; Léanie Kleynhans; Anzaan Dippenaar; Peter E Buss; David V Cooper; Konstantin P Lyashchenko; Robin M Warren; Paul D van Helden; Sven D C Parsons; Michele A Miller
Journal:  Front Vet Sci       Date:  2021-01-28

2.  Adaptation and Diagnostic Potential of a Commercial Cat Interferon Gamma Release Assay for the Detection of Mycobacterium bovis Infection in African Lions (Panthera leo).

Authors:  Rachiel Gumbo; Tashnica T Sylvester; Wynand J Goosen; Peter E Buss; Lin-Mari de Klerk-Lorist; O Louis van Schalkwyk; Alicia McCall; Robin M Warren; Paul D van Helden; Michele A Miller; Tanya J Kerr
Journal:  Pathogens       Date:  2022-07-04

3.  Comparison of interferon gamma release assay and CXCL9 gene expression assay for the detection of Mycobacterium bovis infection in African lions (Panthera leo).

Authors:  Rachiel Gumbo; Tashnica T Sylvester; Sven D C Parsons; Peter E Buss; Robin M Warren; Paul D van Helden; Michele A Miller; Tanya J Kerr
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.